M
Methodsurgical
Health Tech & Medtech · Cleveland, United States · Founded 2021
AI-powered surgical navigation software and planning tools for precision operations MoreLess
Method AI is a medical technology company developing an AI-powered surgical navigation platform to enhance visualization in robotic-assisted oncology procedures. The company was founded in 2021 as a spin-off from the Cleveland Clinic by CEO Doug Teany, a robotics expert and former COO of Corindus, and Dr. Jihad Kaouk, a urologist. Based near Boston, Method AI aims to solve the challenge of surgeons having an incomplete view of tumors during complex operations, particularly in oncology.
The company's core technology utilizes continuous 3D ultrasound imaging and machine learning algorithms to create a real-time, 3D subsurface map of an organ. This platform provides surgeons with real-time guidance based on an AI-generated surgical plan, visualizing anatomy that is deep below the visible surface and beyond the scope of current surgical cameras. The goal is to help surgeons more accurately gauge tumor margins, reduce the chances of leaving cancerous tissue behind, minimize complications, and preserve organ function. By improving precision in tumor removal, the company aims to significantly improve cancer-free survival rates and potentially lower annual healthcare costs by over $1 billion.
Method AI's business model is B2B, targeting hospitals and healthcare providers that perform robotic surgeries. In August 2025, the company secured $20 million in a Series A funding round led by a private family office, with participation from the Cleveland Clinic and the JobsOhio Growth Capital Fund. This capital is intended to support the continued development of its novel surgical ultrasound platform. The platform is currently under development and has not yet been cleared for commercial distribution.
Keywords: surgical navigation, AI in surgery, robotic surgery, 3D ultrasound imaging, oncology procedures, medtech, image-guided surgery, surgical visualization, subsurface mapping, tumor margin assessment, cancer surgery, robotic-assisted surgery, medical imaging, real-time guidance, surgical AI, digital surgery, Cleveland Clinic spinoff, surgical oncology, healthcare technology, medical devices
Company overview
Methodsurgical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- Cleveland, United States
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 77.2
Valuation & funding
Methodsurgical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2025 | $20M | $80M | Cleveland Clinic · JobsOhio | ↗ |
| SPINOUT✓Other financing | May 2021 | $0 | — | University of California, Berkeley | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 15 |
| 2025 | 13 |
Growth signals
Methodsurgical website traffic
Latest recorded traffic for Methodsurgical is 2K monthly website visits, down 20% over the last three months. Methodsurgical's team grew 15.4% over the past year.
Comparisons
Methodsurgical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Methodsurgical's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on Methodsurgical's cap table
Sourced from Dealroom's funding and investor records.




Global footprint
Where Methodsurgical has talent and traffic
team presence
In the news
Latest news about Methodsurgical
Recent press, funding announcements, and product moves mentioning Methodsurgical — open to read from the original sources.
Market sentiment
What the market is saying about Methodsurgical
An AI-synthesized read of the highest-engagement posts about Methodsurgical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Methodsurgical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






